DE19680509T1 - (-)-(3R)-3-Methyl-4-(4-(4-(4pyridyl)piperazin-1-yl)phenoxybuttersäure als Zellaadhäsionsinhibitor - Google Patents
(-)-(3R)-3-Methyl-4-(4-(4-(4pyridyl)piperazin-1-yl)phenoxybuttersäure als ZellaadhäsionsinhibitorInfo
- Publication number
- DE19680509T1 DE19680509T1 DE19680509T DE19680509T DE19680509T1 DE 19680509 T1 DE19680509 T1 DE 19680509T1 DE 19680509 T DE19680509 T DE 19680509T DE 19680509 T DE19680509 T DE 19680509T DE 19680509 T1 DE19680509 T1 DE 19680509T1
- Authority
- DE
- Germany
- Prior art keywords
- 4pyridyl
- piperazin
- methyl
- cell adhesion
- adhesion inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
PCT/GB1996/001260 WO1996038416A1 (en) | 1995-06-01 | 1996-05-28 | (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19680509T1 true DE19680509T1 (de) | 1997-12-04 |
Family
ID=26307696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19680509T Withdrawn DE19680509T1 (de) | 1995-06-01 | 1996-05-28 | (-)-(3R)-3-Methyl-4-(4-(4-(4pyridyl)piperazin-1-yl)phenoxybuttersäure als Zellaadhäsionsinhibitor |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0796247A1 (sv) |
JP (1) | JP2885941B2 (sv) |
KR (1) | KR100245957B1 (sv) |
AT (1) | AT406675B (sv) |
AU (1) | AU710105B2 (sv) |
BE (1) | BE1009520A5 (sv) |
BR (1) | BR9606409A (sv) |
CA (1) | CA2194397A1 (sv) |
CH (1) | CH691808A5 (sv) |
CZ (1) | CZ26997A3 (sv) |
DE (1) | DE19680509T1 (sv) |
DK (1) | DK10697A (sv) |
ES (1) | ES2137886B1 (sv) |
FI (1) | FI970393L (sv) |
GB (1) | GB2304340B (sv) |
GR (1) | GR1002702B (sv) |
HU (1) | HUP9700274A3 (sv) |
IE (1) | IE960405A1 (sv) |
IL (1) | IL118477A0 (sv) |
IT (1) | IT1290839B1 (sv) |
LU (1) | LU90008B1 (sv) |
MC (1) | MC2418A1 (sv) |
MX (1) | MX9700379A (sv) |
NL (1) | NL1003243C2 (sv) |
NO (1) | NO307460B1 (sv) |
NZ (1) | NZ308597A (sv) |
PL (1) | PL318440A1 (sv) |
SE (1) | SE510812C2 (sv) |
SK (1) | SK13097A3 (sv) |
TR (1) | TR199700020T1 (sv) |
WO (1) | WO1996038416A1 (sv) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
AU692439B2 (en) * | 1993-03-29 | 1998-06-11 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
PT825184E (pt) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | Derivados heterociclicos como inibidores de agregacao de plaquetas |
-
1996
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/en not_active IP Right Cessation
- 1996-05-28 CA CA002194397A patent/CA2194397A1/en not_active Abandoned
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 EP EP96919906A patent/EP0796247A1/en not_active Withdrawn
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-29 MC MC2347A patent/MC2418A1/xx unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 FI FI970393A patent/FI970393L/sv unknown
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980097L (no) | Celleadhesjonsinhibitorer | |
ID23668A (id) | Turunan asam ariloksiarilsulfonilamino hidroksamat | |
ID21140A (id) | Metode produksi asam akrilat | |
DE59601770D1 (de) | Substituierte quaterrylentetracarbonsäurediimide | |
DE69522690D1 (de) | alpha-ketogultarsäure dehydrogenasegen | |
ATE211131T1 (de) | Arylsulfonylaminohydroxamsäurederivate | |
FI973087L (sv) | Inhibitorer för celladhesion | |
DE60012883D1 (de) | 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepin-3-hydroxamsäure als matrix metalloproteinaseinhibitoren | |
ID20807A (id) | Asam sulfonilaminokarboksilat | |
DE60041256D1 (de) | Mono-substituierte 3-propyl-gamma-aminobuttersäure | |
DE69616892D1 (de) | Adhäsivbandabgabevorrichtung | |
DE60011568D1 (de) | Derivativen von monosacchariden als zelladhäsionshemmer | |
DE59606674D1 (de) | Hydroximsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel und fungizide | |
DE19680509T1 (de) | (-)-(3R)-3-Methyl-4-(4-(4-(4pyridyl)piperazin-1-yl)phenoxybuttersäure als Zellaadhäsionsinhibitor | |
EP0671406A3 (en) | Beta-glycolipid sulphate derivatives as cell adhesion inhibitors. | |
NO980994D0 (no) | Substituerte fosfinsyreforbindelser og deres anvendelse som farmasöytika | |
EE200000239A (et) | Uued metüleenbisfosfoonhappe derivaadid | |
KR970006550U (ko) | 모자이크화된 온돌용 판 | |
DE69616661D1 (de) | Optisch-aktives Monophosphino-Carbonsäurederivat | |
ITPG950012V0 (it) | Contromarca (fox room) | |
DE69612427D1 (de) | Klebebandabgabegerät | |
ITPG950005V0 (it) | Contromarca (fox-room) | |
BR7500645U (pt) | Disposição construtiva aplicada a óculos | |
KR970009974U (ko) | 도어체커플레이트 | |
KR970007085U (ko) | 음악 정보 확인 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8181 | Inventor (new situation) |
Free format text: MILLS, STUART, MACCLESFIELD, CHESHIRE, GB |
|
8180 | Miscellaneous part 1 |
Free format text: DIE BEZEICHNUNG IST ZU AENDERN IN: (-)-(3R)-3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BUTTERSAEURE ALS ZELLADHAESIONSINHIBITOR |
|
8139 | Disposal/non-payment of the annual fee |